[1]
Yilmaz, I., Bilir, B., Dogan, M., Karaarslan, N. and Ozbek, H. 2022. Evaluation of inflammatory and biochemical markers in COVID-19 patients treated with tocilizumab alone or with the combination of tocilizumab and convalescent plasma transfusion. Annals of Medical Research. 29, 7 (Jul. 2022), 770–776.